Embecta Corp. Share Price

Equities

EMBC

US29082K1051

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 31/05/2024 BST 5-day change 1st Jan Change
12.37 USD -0.48% Intraday chart for Embecta Corp. -5.79% -34.65%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 1.12B 87.53B Sales 2025 * 1.12B 87.84B Capitalization 713M 55.98B
Net income 2024 * 70M 5.49B Net income 2025 * 98M 7.69B EV / Sales 2024 * 1.75 x
Net Debt 2024 * 1.24B 97.08B Net Debt 2025 * 1.11B 87.37B EV / Sales 2025 * 1.63 x
P/E ratio 2024 *
10.2 x
P/E ratio 2025 *
7.47 x
Employees 2,200
Yield 2024 *
4.62%
Yield 2025 *
4.54%
Free-Float 99.53%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.48%
1 week-5.79%
1 month+20.92%
3 months-12.64%
6 months-32.84%
Current year-34.65%
More quotes
1 week
12.27
Extreme 12.27
13.44
1 month
10.15
Extreme 10.15
15.28
Current year
9.93
Extreme 9.925
19.79
1 year
9.93
Extreme 9.925
28.36
3 years
0.00
Extreme 0
49.00
5 years
0.00
Extreme 0
49.00
10 years
0.00
Extreme 0
49.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 21/03/22
Director of Finance/CFO 51 21/03/22
Chief Tech/Sci/R&D Officer 60 30/09/21
Members of the board TitleAgeSince
Director/Board Member 68 31/03/22
Director/Board Member 60 31/03/22
Director/Board Member 58 19/03/22
More insiders
Date Price Change Volume
31/05/24 12.37 -0.48% 994,576
30/05/24 12.43 -2.43% 233,914
29/05/24 12.74 -2.67% 315,997
28/05/24 13.09 -0.30% 428,427

Delayed Quote Nasdaq, May 31, 2024 at 09:00 pm

More quotes
Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes. The Company has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The Company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.37 USD
Average target price
15 USD
Spread / Average Target
+21.26%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW